Twin Atlas
Live data, research and proof in one view — owner only
Research and engineering view, not medical advice. No personal DNA sequence is stored for the twin yet, so the gene panel below shows published reference variants for the genes under research, not the twin's own genotype.
Twin
Open
—
Live readings
61
latest 139d ago
Within ±1 SD
51%
of readings vs baseline
Reference variants
111
77 flagged
Chain proof
Intact
193 audit entries checked
1 · Live readings compared with the twin's baseline
Where it should be
z between −1 and +1 (at baseline = 0). −2 to +2 is the watch band.
Trend
Rising 0.031 SD per hour; z ≈ 1.22 now.
Straight-line projection (same window ahead)
z ≈ 2.30 leaves reference range
The projection extends a fitted line; it is not a forecast of health. Source: mesh_node_readings.deviation_z. Bands: 31 within, 24 watch, 6 outside.
2 · Reference chemistry the twin is compared against
| Chemical | Class | Baseline | ±1 SD (68%) | ±2 SD (95%) | Unit |
|---|---|---|---|---|---|
| adrenaline | HORMONE | 60 | 40 – 80 | 20 – 100 | pg/mL |
| cortisol | HORMONE | 450 | 330 – 570 | 210 – 690 | nmol/L |
| insulin | HORMONE | 8 | 5 – 11 | 2 – 14 | µIU/mL |
| melatonin | HORMONE | 25 | 15 – 35 | 5 – 45 | pg/mL |
| oxytocin | HORMONE | 18 | 12 – 24 | 6 – 30 | pg/mL |
| testosterone | HORMONE | 16.5 | 12 – 21 | 7.5 – 25.5 | nmol/L |
| dopamine | NEUROTRANSMITTER | 0.12 | 0.08 – 0.16 | 0.04 – 0.2 | ng/mL |
| gaba | NEUROTRANSMITTER | 2 | 1.5 – 2.5 | 1 – 3 | µmol/L |
| glutamate | NEUROTRANSMITTER | 60 | 45 – 75 | 30 – 90 | µmol/L |
| norepinephrine | NEUROTRANSMITTER | 280 | 200 – 360 | 120 – 440 | pg/mL |
| serotonin | NEUROTRANSMITTER | 180 | 140 – 220 | 100 – 260 | ng/mL |
| bicarbonate | ELECTROLYTE | 25 | 23 – 27 | 21 – 29 | mEq/L |
| calcium | ELECTROLYTE | 9.5 | 9 – 10 | 8.5 – 10.5 | mg/dL |
| chloride | ELECTROLYTE | 102 | 100 – 104 | 98 – 106 | mEq/L |
| magnesium | ELECTROLYTE | 2 | 1.8 – 2.2 | 1.6 – 2.4 | mg/dL |
| potassium | ELECTROLYTE | 4.2 | 3.8 – 4.6 | 3.4 – 5 | mEq/L |
| sodium | ELECTROLYTE | 140 | 137.5 – 142.5 | 135 – 145 | mEq/L |
| glucose | METABOLITE | 90 | 80 – 100 | 70 – 110 | mg/dL |
| lactate | METABOLITE | 1 | 0.7 – 1.3 | 0.4 – 1.6 | mmol/L |
No measured values for these chemicals are stored yet, so they cannot be placed on the scale. The convergence cortisol is a normalised gate value and is deliberately not compared with these laboratory units.
3 · DNA: what the research flags (reference variants by gene)
PathogenicLikely pathogenicUncertain significanceLikely benignBenignOther
What was wrong (in the literature)
- Pathogenic NM_007294.4(BRCA1):c.387del (p.Tyr130fs) · BRCA1
- Likely pathogenic NM_000059.4(BRCA2):c.2637dup (p.Glu880Ter) · BRCA2
- Pathogenic GRCh38/hg38 9p24.3-q34.11(chr9:46587-128255422)x3 · LOC126860752
- Likely pathogenic NM_020937.4(FANCM):c.5653C>T (p.Gln1885Ter) · FANCM
- Pathogenic NM_024675.4(PALB2):c.827dup (p.His276fs) · PALB2
- Likely pathogenic NM_000360.4(TH):c.241del (p.Val81fs) · TH
- Likely pathogenic NM_000360.4(TH):c.829del (p.Arg277fs) · TH
- Likely pathogenic NM_000360.4(TH):c.1188C>A (p.Tyr396Ter) · TH
- Likely pathogenic NM_000360.4(TH):c.977+2T>C · TH
- Likely pathogenic NM_001082971.2(DDC):c.1039C>G (p.Arg347Gly) · DDC
- Likely pathogenic NM_001082971.2(DDC):c.1141-2A>G · DDC
- Likely pathogenic NM_001082971.2(DDC):c.200G>T (p.Gly67Val) · DDC
- Pathogenic NM_001082971.2(DDC):c.996C>G (p.Tyr332Ter) · DDC
- Likely pathogenic NM_001044.5(SLC6A3):c.188G>A (p.Trp63Ter) · SLC6A3
- Likely pathogenic NM_001044.5(SLC6A3):c.941C>T (p.Ala314Val) · SLC6A3
- Likely pathogenic NM_001044.5(SLC6A3):c.1708dup (p.Ala570fs) · SLC6A3
- Pathogenic NM_001044.5(SLC6A3):c.1762C>T (p.Arg588Ter) · SLC6A3
- Likely pathogenic NM_000240.4(MAOA):c.1052+1G>A · MAOA
- Likely pathogenic NM_000240.4(MAOA):c.595A>T (p.Lys199Ter) · MAOA
- Likely pathogenic NM_000240.4(MAOA):c.1075del (p.Asp359fs) · MAOA
- Pathogenic NM_000240.4(MAOA):c.1183A>T (p.Lys395Ter) · MAOA
- Likely pathogenic NM_001045.6(SLC6A4):c.1745dup (p.Thr583fs) · SLC6A4
- Likely pathogenic NM_000787.4(DBH):c.409C>T (p.Gln137Ter) · DBH
- Likely pathogenic NM_000787.4(DBH):c.486+1G>A · DBH
- Likely pathogenic NM_000787.4(DBH):c.692G>A (p.Trp231Ter) · DBH
- Pathogenic NM_000787.4(DBH):c.223C>T (p.Gln75Ter) · DBH
- Pathogenic NM_001172501.3(SLC6A2):c.1369G>C (p.Ala457Pro) · SLC6A2
- Likely pathogenic NM_020549.5(CHAT):c.1468_1469del (p.Glu490fs) · CHAT
- Likely pathogenic NM_020549.5(CHAT):c.485del (p.Ser162fs) · CHAT
- Likely pathogenic NM_020549.5(CHAT):c.286+2T>C · CHAT
- Likely pathogenic NM_020549.5(CHAT):c.917T>C (p.Val306Ala) · CHAT
- Pathogenic GRCh37/hg19 15q13.3(chr15:31982511-32444044)x1 · CHRNA7
- Likely pathogenic NM_000817.3(GAD1):c.1264-350_1289delinsGAGGTATCCAGCACATCCTGGCTG · GAD1
- Pathogenic NM_000817.3(GAD1):c.87C>A (p.Tyr29Ter) · GAD1
- Likely pathogenic NM_000817.3(GAD1):c.611G>A (p.Trp204Ter) · GAD1
- Likely pathogenic NM_000817.3(GAD1):c.719C>G (p.Ser240Ter) · GAD1
- Likely pathogenic NM_001127644.2(GABRA1):c.778C>T (p.Pro260Ser) · GABRA1
- Likely pathogenic NM_001127644.2(GABRA1):c.476+2_476+6del · GABRA1
- Likely pathogenic NM_001127644.2(GABRA1):c.433C>T (p.Leu145Phe) · GABRA1
- Likely pathogenic NM_001127644.2(GABRA1):c.881C>A (p.Thr294Lys) · GABRA1
- Likely pathogenic NM_198904.4(GABRG2):c.705G>A (p.Trp235Ter) · GABRG2
- Likely pathogenic NM_198904.4(GABRG2):c.497_498del (p.Pro166fs) · GABRG2
- Likely pathogenic NM_198904.4(GABRG2):c.333C>G (p.Tyr111Ter) · GABRG2
- Likely pathogenic NM_198904.4(GABRG2):c.373C>A (p.Arg125Ser) · GABRG2
- Likely pathogenic NM_001134407.3(GRIN2A):c.304del (p.Asp102fs) · GRIN2A
- Likely pathogenic NM_001134407.3(GRIN2A):c.675dup (p.Val226fs) · GRIN2A
- Likely pathogenic NM_001134407.3(GRIN2A):c.1007_1007+2delinsAAGGTGTGCACAAAGGTGCACACCCGATGCACCTTTCTTGCAAC · GRIN2A
- Likely pathogenic NM_001134407.3(GRIN2A):c.1122+1G>A · GRIN2A
- Likely pathogenic NM_000834.5(GRIN2B):c.2804C>G (p.Ser935Ter) · GRIN2B
- Likely pathogenic NM_000834.5(GRIN2B):c.1673T>C (p.Val558Ala) · GRIN2B
- Likely pathogenic NM_000834.5(GRIN2B):c.1736_1739del (p.Tyr579fs) · GRIN2B
- Likely pathogenic NM_000834.5(GRIN2B):c.1916C>A (p.Ala639Asp) · GRIN2B
- Likely pathogenic NM_004171.4(SLC1A2):c.266T>C (p.Leu89Pro) · SLC1A2
- Likely pathogenic NM_004171.4(SLC1A2):c.1625A>G (p.His542Arg) · SLC1A2
- Likely pathogenic NM_004171.4(SLC1A2):c.746del (p.Phe249fs) · SLC1A2
- Likely pathogenic NM_004171.4(SLC1A2):c.827T>G (p.Ile276Ser) · SLC1A2
- Likely pathogenic NM_000176.3(NR3C1):c.1489del (p.Lys496_Ile497insTer) · NR3C1
- Pathogenic NM_000176.3(NR3C1):c.1471C>T (p.Arg491Ter) · NR3C1
- Likely pathogenic NM_000176.3(NR3C1):c.2182-1G>A · NR3C1
- Likely pathogenic NM_000176.3(NR3C1):c.2009T>C (p.Leu670Pro) · NR3C1
- Pathogenic NM_001165963.4(SCN1A):c.413T>C (p.Ile138Thr) · SCN1A
- Pathogenic NM_001165963.4(SCN1A):c.195T>A (p.Tyr65Ter) · SCN1A
- Likely pathogenic NM_001165963.4(SCN1A):c.250T>C (p.Tyr84His) · SCN1A
- Likely pathogenic NM_001165963.4(SCN1A):c.317C>T (p.Ser106Phe) · SCN1A
- Likely pathogenic NM_000484.4(APP):c.2138C>A (p.Ala713Glu) · APP
- Likely pathogenic NM_000484.4(APP):c.2059A>C (p.Lys687Gln) · APP
- Pathogenic NC_000021.8:g.(?_27252860)_(27543089_?)dup · APP
- Likely pathogenic NM_000484.4(APP):c.2061A>C (p.Lys687Asn) · APP
- Likely pathogenic NM_000021.4(PSEN1):c.844C>A (p.Leu282Ile) · PSEN1
- Likely pathogenic NM_000021.4(PSEN1):c.1268T>C (p.Leu423Ser) · PSEN1
- Likely pathogenic NM_000021.4(PSEN1):c.701C>T (p.Ala234Val) · PSEN1
- Pathogenic NM_000021.4(PSEN1):c.238A>C (p.Lys80Gln) · PSEN1
- Likely pathogenic NM_000041.4(APOE):c.14G>A (p.Trp5Ter) · APOE
- Likely pathogenic NM_000041.4(APOE):c.300_303del (p.Thr101fs) · APOE
- Likely pathogenic NM_000041.4(APOE):c.461G>A (p.Arg154His) · APOE
- Likely pathogenic NM_000041.4(APOE):c.548G>C (p.Gly183Ala) · APOE
- Pathogenic GRCh38/hg38 2p25.1-23.3(chr2:7911603-25790311)x1 · LOC129388819
Where it needs to be, and the edit
The reference state for each gene is no pathogenic variant. A planned edit is shown here as: reference sequence → variant → edited sequence, with the guide, the cut site and the protein effect.
Edits recorded: 0 · Twin DNA records: 0 — add a sequence to compare it with these references (the data vault and CRISPR simulator are the next steps).
4 · Agents: where each record came from
| Source | Records |
|---|---|
| clinvar | 111 |
| brain_paper | 95 |
| crispr_guide | 40 |
| europepmc | 38 |
| pubmed | 34 |
| trial | 28 |
| nih_grant | 19 |
| stjude | 9 |
| topic_summary | 8 |
| crispr_paper | 6 |
| stjude_dataset | 5 |
| crispr_preprint | 5 |
| brain_preprint | 5 |
| ncbi_datasets | 4 |
| Agent | Cycle | Topic | New | Run |
|---|---|---|---|---|
| 50346c27ba992a8f | 1791558593 | breast cancer · GEN1 | 15 | 5d ago |
| 50346c27ba992a8f | 1791552216 | breast cancer · EME1 | 15 | 5d ago |
| 50346c27ba992a8f | 1791548602 | breast cancer · PALB2 | 23 | 5d ago |
| 50346c27ba992a8f | 1791544994 | breast cancer · FANCM | 15 | 5d ago |
| 50346c27ba992a8f | 1791541384 | breast cancer · RMI1 | 14 | 5d ago |
| 50346c27ba992a8f | 1791537772 | breast cancer · PARP1 | 28 | 5d ago |
| 50346c27ba992a8f | 1791533853 | breast cancer · BRCA2 | 6 | 5d ago |
| 50346c27ba992a8f | 1791533836 | breast cancer · BRCA1 | 0 | 5d ago |
5 · Proof: how the data is tied to the chain
- Audit trail
- Hash links intact 193 newest entries re-checked. Latest: e090f3c42aa7ecd5abec… · 2026-10-10 16:41:06Z
- Chain blocks
- 38
- XRP Ledger anchors
- None yet Anchors hold only a hash of a record or an approval, never names, sequences or health values.
- Research topics
- 9 explored · 8 queued
Each agent write is signed on arrival, recorded in the audit trail, and chained to the entry before it. Anchoring a hash to the ledger lets anyone holding the original record prove it was not changed.